Search Results - "Steinhoff, M M"
-
1
Pathophysiology and therapy of pruritus in allergic and atopic diseases
Published in Allergy (Copenhagen) (01-07-2010)“…To cite this article: Buddenkotte J, Steinhoff M. Pathophysiology and therapy of pruritus in allergic and atopic diseases. Allergy 2010; 65: 805-821. Pruritus…”
Get full text
Journal Article -
2
Prevalence, pathophysiology and management of itch in epidermolysis bullosa
Published in British journal of dermatology (1951) (01-05-2021)“…Summary Epidermolysis bullosa (EB) is a highly diverse group of inherited skin disorders, resulting from mutations in genes encoding proteins of the…”
Get full text
Journal Article -
3
Lichen planus: a comprehensive evidence‐based analysis of medical treatment
Published in Journal of the European Academy of Dermatology and Venereology (01-10-2019)“…Lichen planus (LP) is a chronic‐relapsing inflammatory skin disease. Although many drugs have been used for the management of LP, some of them lack the backup…”
Get full text
Journal Article -
4
Potential role of INTERLEUKIN‐17 in the pathogenesis of oral lichen planus: a systematic review with META‐analysis
Published in Journal of the European Academy of Dermatology and Venereology (01-10-2022)“…Oral lichen planus (OLP) is a chronic inflammatory mucocutaneous disease of unknown aetiology, which may evolve into squamous cell carcinoma. Recent advances…”
Get full text
Journal Article -
5
Role of protease-activated receptors in inflammatory responses, innate and adaptive immunity
Published in Journal of leukocyte biology (01-06-2008)“…Serine proteases are well known as enzymes involved in digestion of dietary proteins, blood coagulation, and homeostasis. Only recent groundbreaking studies…”
Get full text
Journal Article -
6
Evidence supporting the enhanced efficacy of pentavalent antimonials with adjuvant therapy for cutaneous leishmaniasis: a systematic review and meta‐analysis
Published in Journal of the European Academy of Dermatology and Venereology (01-10-2020)“…Cutaneous leishmaniasis (CL) is one of the major neglected disease worldwide. Although many drugs have been used, the pentavalent antimonials (PA) remain as…”
Get full text
Journal Article -
7
Molecular mechanisms of pruritus
Published in Current research in translational medicine (01-10-2016)“…Pruritus is an unpleasant sensation that evokes the urgent desire to scratch. It is a symptom derived from many nervous system disorders that affects a large…”
Get full text
Journal Article -
8
Recommendations for rosacea diagnosis, classification and management: update from the global ROSacea COnsensus 2019 panel
Published in British journal of dermatology (1951) (01-05-2020)“…Summary Background A transition from a subtyping to a phenotyping approach in rosacea is underway, allowing individual patient management according to…”
Get full text
Journal Article -
9
Updating the diagnosis, classification and assessment of rosacea: recommendations from the global ROSacea COnsensus (ROSCO) panel
Published in British journal of dermatology (1951) (01-02-2017)“…Summary Background Rosacea is currently diagnosed by consensus‐defined primary and secondary features and managed by subtype. However, individual features…”
Get full text
Journal Article Conference Proceeding -
10
Rosacea treatment update: recommendations from the global ROSacea COnsensus (ROSCO) panel
Published in British journal of dermatology (1951) (01-02-2017)“…Summary Background Rosacea is currently treated according to subtypes. As this does not adequately address the spectrum of clinical presentation (phenotypes),…”
Get full text
Journal Article Conference Proceeding -
11
Once-daily topical brimonidine tartrate gel 0·5% is a novel treatment for moderate to severe facial erythema of rosacea: results of two multicentre, randomized and vehicle-controlled studies
Published in British journal of dermatology (1951) (01-03-2012)“…Summary Background Erythema of rosacea is thought to result from abnormal cutaneous vasomotor activity. Brimonidine tartrate (BT) is a highly selective…”
Get full text
Journal Article -
12
Protease-activated receptor-2 activation: a major actor in intestinal inflammation
Published in Gut (01-09-2008)“…The role of protease-activated receptor-2 (PAR(2)) during intestinal inflammation is still unclear due to the fact that PAR(2)-activating peptide has both pro-…”
Get more information
Journal Article -
13
Phase III Randomized Trial of Weekly Cisplatin and Irradiation Versus Cisplatin and Tirapazamine and Irradiation in Stages IB2, IIA, IIB, IIIB, and IVA Cervical Carcinoma Limited to the Pelvis: A Gynecologic Oncology Group Study
Published in Journal of clinical oncology (10-02-2014)“…This prospective, randomized phase III intergroup trial of the Gynecologic Oncology Group and National Cancer Institute of Canada Clinical Trials Group was…”
Get full text
Journal Article -
14
Distribution of GPR30, a Seven Membrane–Spanning Estrogen Receptor, in Primary Breast Cancer and its Association with Clinicopathologic Determinants of Tumor Progression
Published in Clinical cancer research (01-11-2006)“…Purpose: The seven transmembrane receptor, GPR30, is linked to estrogen binding and heparan-bound epidermal growth factor release. Here, the significance of…”
Get full text
Journal Article -
15
Protease-activated receptors: novel PARtners in innate immunity
Published in Trends in immunology (01-12-2007)“…Protease-activated receptors (PARs) belong to a family of G protein-coupled receptors activated by serine proteases via proteolytic cleavage. PARs are…”
Get full text
Journal Article -
16
IL-31: A new link between T cells and pruritus in atopic skin inflammation
Published in Journal of Allergy and Clinical Immunology (01-02-2006)“…IL-31 is a novel T-cell–derived cytokine that induces severe pruritus and dermatitis in transgenic mice, and signals through a heterodimeric receptor composed…”
Get full text
Journal Article -
17
Quality of life measurement in rosacea. Position statement of the European Academy of Dermatology and Venereology Task Forces on Quality of Life and Patient Oriented Outcomes and Acne, Rosacea and Hidradenitis Suppurativa
Published in Journal of the European Academy of Dermatology and Venereology (01-05-2023)“…The European Academy of Dermatology and Venereology (EADV) Task Forces (TFs) on Quality of Life (QoL) and Patient‐Oriented Outcomes and Acne, Rosacea and…”
Get full text
Journal Article -
18
Psychoneuroimmunology of Psychological Stress and Atopic Dermatitis: Pathophysiologic and Therapeutic Updates
Published in Acta dermato-venereologica (2012)“…Atopic dermatitis is a chronic inflammatory skin disease characterized by impaired epidermal barrier function, inflammatory infiltration, extensive pruritus…”
Get full text
Journal Article -
19
Serum HE4 levels are less frequently elevated than CA125 in women with benign gynecologic disorders
Published in American journal of obstetrics and gynecology (01-04-2012)“…Objective The human epididymis protein 4 (HE4) is a novel biomarker for ovarian cancer. This study measured the HE4 and CA125 levels in women with benign…”
Get full text
Journal Article -
20
Shortcomings in rosacea diagnosis and classification
Published in British journal of dermatology (1951) (01-01-2017)Get full text
Journal Article